» Articles » PMID: 9732005

A New Model of Epidermal Culture for the Surgical Treatment of Vitiligo

Overview
Journal Int J Dermatol
Specialty Dermatology
Date 1998 Sep 10
PMID 9732005
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Vitiligo can be successfully treated with grafts of autologous cultured epidermal cells.

Objective: To evaluate the efficacy of autologous grafting of epidermal cells, cultured by an original method, in the treatment of localized vitiligo refractory to other therapies.

Methods: Autologous normally pigmented skin was used to culture keratinocytes and melanocytes on a supporting layer of biomaterial (Laserskin), which was grafted directly onto achromatic skin after de-epithelialization with liquid carbon dioxide. The percentage area of repigmentation was calculated by image analysis.

Results: Initial repigmentation of the treated areas was observed 1 month after treatment. Repigmentation continued to increase for 3 months after grafting. Follow-up at 3, 6, 12, and 18 months showed almost complete repigmentation in six out of 11 cases. In four other patients, 40-71% of the grafted achromatic area was repigmented. In one patient, repigmentation was impeded by sepsis.

Conclusions: The method was found to be effective in the treatment of localized vitiligo refractory to other treatments. The therapeutic procedure was simple, reproducible, and easy to use.

Citing Articles

Wound Healing: Biologics, Skin Substitutes, Biomembranes and Scaffolds.

Vyas K, Vasconez H Healthcare (Basel). 2016; 2(3):356-400.

PMID: 27429283 PMC: 4934597. DOI: 10.3390/healthcare2030356.


Stem Cells in Skin Regeneration, Wound Healing, and Their Clinical Applications.

Ojeh N, Pastar I, Tomic-Canic M, Stojadinovic O Int J Mol Sci. 2015; 16(10):25476-501.

PMID: 26512657 PMC: 4632811. DOI: 10.3390/ijms161025476.


Cell therapy in dermatology.

Petrof G, Abdul-Wahab A, McGrath J Cold Spring Harb Perspect Med. 2014; 4(6).

PMID: 24890834 PMC: 4031958. DOI: 10.1101/cshperspect.a015156.


Amniotic membrane as a scaffold for melanocyte transplantation in patients with stable vitiligo.

Redondo P, Gimenez de Azcarate A, Marques L, Garcia-Guzman M, Andreu E, Prosper F Dermatol Res Pract. 2011; 2011:532139.

PMID: 21869882 PMC: 3159018. DOI: 10.1155/2011/532139.


Current and emerging therapy for the management of vitiligo.

Bordere A, Lambert J, van Geel N Clin Cosmet Investig Dermatol. 2011; 2:15-25.

PMID: 21436965 PMC: 3047938.